Technical Analysis for IKT - Inhibikase Therapeutics, Inc.

Grade Last Price % Change Price Change
F 2.4 5.26% 0.12
IKT closed up 5.26 percent on Thursday, July 29, 2021, on 63 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up
Historical IKT trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Calm After Storm Range Contraction 5.26%
Lower Bollinger Band Walk Weakness 5.26%
Wide Bands Range Expansion 5.26%
Lower Bollinger Band Touch Weakness 5.26%
New 52 Week Closing Low Bearish 10.09%
Lower Bollinger Band Walk Weakness 10.09%
New 52 Week Low Weakness 10.09%
Below Lower BB Weakness 10.09%
Older End-of-Day Signals for IKT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 4 hours ago
60 Minute Opening Range Breakout about 7 hours ago
Rose Above 10 DMA about 7 hours ago
Up 5% about 7 hours ago
10 DMA Resistance about 7 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inhibikase Therapeutics, Inc. Description

Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease, and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a c-Abl protein kinase inhibitor for use in the treatment of Parkinson's Disease, dysphagia, and neurogenic constipation; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects. Its research phase products comprise IkT-01427, a product candidate that blocks the causative virus of progressive multifocal leukoencephalopathy from replicating in the body; and IkT-148x series of portfolio compounds for use in the treatment of Dementia with Lewy Body and Multiple System Atrophy. The company was founded in 2008 and is headquartered in Atlanta, Georgia


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Parkinson's Disease Neurological Disorders Stage Pharmaceutical Psychiatric Diagnosis Dementia Treatment Of Parkinson's Disease Aging Associated Diseases Neurodegenerative Disorders Pyridines Related Disorders Imatinib Lewy Body Dementia

Is IKT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.8
52 Week Low 2.03
Average Volume 899,492
200-Day Moving Average 0.00
50-Day Moving Average 3.64
20-Day Moving Average 2.53
10-Day Moving Average 2.38
Average True Range 0.26
ADX 36.7
+DI 12.54
-DI 28.23
Chandelier Exit (Long, 3 ATRs) 2.14
Chandelier Exit (Short, 3 ATRs) 2.82
Upper Bollinger Bands 2.90
Lower Bollinger Band 2.16
Percent B (%b) 0.33
BandWidth 29.38
MACD Line -0.34
MACD Signal Line -0.40
MACD Histogram 0.0611
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.73
Resistance 3 (R3) 2.70 2.56 2.68
Resistance 2 (R2) 2.56 2.48 2.58 2.66
Resistance 1 (R1) 2.48 2.42 2.52 2.51 2.64
Pivot Point 2.34 2.34 2.36 2.36 2.34
Support 1 (S1) 2.26 2.26 2.30 2.29 2.16
Support 2 (S2) 2.12 2.20 2.14 2.14
Support 3 (S3) 2.04 2.12 2.13
Support 4 (S4) 2.07